Home › Trial NCT02400385
A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma
- Trial IDNCT02400385
- StatusWithdrawn
- PhasePhase 2
- Study typeInterventional
- SponsorCalifornia Pacific Medical Center Research Institute
- Enrollment—
- Start date2014-10
- ConditionsMelanoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.